(Q43679852)

25 November 2017

Studies towards the next generation of antidepressants. Part 1: Indolylcyclohexylamines as potent serotonin reuptake inhibitors (English)

1 reference

25 November 2017

0 references

Meagher KL

1

1 reference

25 November 2017

Mewshaw RE

2

1 reference

25 November 2017

Evrard DA

3

1 reference

25 November 2017

Zhou P

4

1 reference

25 November 2017

Smith DL

5

1 reference

25 November 2017

Scerni R

6

1 reference

25 November 2017

Spangler T

7

1 reference

25 November 2017

Abulhawa S

8

1 reference

25 November 2017

Shi X

9

1 reference

25 November 2017

Schechter LE

10

1 reference

25 November 2017

Andree TH

11

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Bioorganic & Medicinal Chemistry Letters

25 November 2017

1 reference

25 November 2017

11

1 reference

25 November 2017

1885-1888

1 reference

25 November 2017

14

1 reference

Contemporary management of depression

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

Adverse effects of antidepressant drugs. Part 1: monoamine oxidase inhibitors and tricyclics

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

3-(4-Piperidinylalkyl)indoles, selective inhibitors of neuronal 5-hydroxytryptamine uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

Inhibition of phenylethanolamine N-methyltransferase (PNMT) by aromatic hydroxy-substituted 1,2,3,4,-tetrahydroisoquinolines: further studies on the hydrophilic pocket of the aromatic ring binding region of the active site

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

[3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900334-1

7 January 2021

10.1016/S0960-894X(01)00334-1

Identifiers

DOI

1 reference

25 November 2017

1 reference